| 0 |
VAGINAL FLATULENCE |
148 |
0.4884 |
| 1 |
AMYLOID ARTHROPATHY |
29 |
0.4143 |
| 2 |
PSEUDOHYPOPYON |
4 |
0.3333 |
| 3 |
TRANSFERRIN SATURATION ABNORMAL |
5 |
0.2941 |
| 4 |
CARBOHYDRATE ANTIGEN 15-3 |
3 |
0.1000 |
| 5 |
FEMALE GENITAL TRACT FISTULA |
159 |
0.0930 |
| 6 |
TOTAL LUNG CAPACITY INCREASED |
23 |
0.0846 |
| 7 |
CARBUNCLE |
23 |
0.0813 |
| 8 |
PRODUCT ADMINISTRATION ISSUE |
14 |
0.0670 |
| 9 |
ANAL INFLAMMATION |
38 |
0.0595 |
| 10 |
RADICULOPATHY |
154 |
0.0584 |
| 11 |
PROCTITIS |
148 |
0.0528 |
| 12 |
CHRONIC SINUSITIS |
198 |
0.0527 |
| 13 |
SARS-COV-2 TEST NEGATIVE |
33 |
0.0489 |
| 14 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
23 |
0.0440 |
| 15 |
MACULAR DEGENERATION |
460 |
0.0385 |
| 16 |
ASYMPTOMATIC BACTERIURIA |
5 |
0.0368 |
| 17 |
DUODENAL NEOPLASM |
3 |
0.0306 |
| 18 |
MONOCLONAL IMMUNOGLOBULIN PRESENT |
22 |
0.0289 |
| 19 |
ANAL EROSION |
3 |
0.0273 |
| 20 |
WRIST DEFORMITY |
15 |
0.0244 |
| 21 |
DERMATOPHYTOSIS |
6 |
0.0211 |
| 22 |
GLOMERULONEPHRITIS CHRONIC |
3 |
0.0160 |
| 23 |
SERUM FERRITIN ABNORMAL |
5 |
0.0156 |
| 24 |
FAMILIAL MEDITERRANEAN FEVER |
3 |
0.0153 |
| 25 |
HYPOTHALAMO-PITUITARY DISORDER |
22 |
0.0151 |
| 26 |
GASTROSTOMY TUBE SITE COMPLICATION |
3 |
0.0150 |
| 27 |
VAGINAL DISCHARGE |
149 |
0.0147 |
| 28 |
PARAESTHESIA ORAL |
198 |
0.0137 |
| 29 |
MIGRAINE WITHOUT AURA |
4 |
0.0133 |
| 30 |
NEUROBLASTOMA |
5 |
0.0131 |
| 31 |
ORAL CANDIDIASIS |
150 |
0.0114 |
| 32 |
MENINGOENCEPHALITIS HERPETIC |
5 |
0.0112 |
| 33 |
CREATININE RENAL CLEARANCE ABNORMAL |
5 |
0.0108 |
| 34 |
PULMONARY PAIN |
31 |
0.0106 |
| 35 |
FEEDING INTOLERANCE |
4 |
0.0089 |
| 36 |
PROCTALGIA |
57 |
0.0089 |
| 37 |
DERMATITIS DIAPER |
6 |
0.0085 |
| 38 |
GINGIVAL ERYTHEMA |
7 |
0.0081 |
| 39 |
TYPE III IMMUNE COMPLEX MEDIATED REACTION |
4 |
0.0072 |
| 40 |
FIBROSIS |
22 |
0.0071 |
| 41 |
ALVEOLAR OSTEITIS |
3 |
0.0071 |
| 42 |
JARISCH-HERXHEIMER REACTION |
5 |
0.0070 |
| 43 |
PROCEDURAL PAIN |
190 |
0.0068 |
| 44 |
JAUNDICE CHOLESTATIC |
24 |
0.0068 |
| 45 |
PNEUMONIA STREPTOCOCCAL |
7 |
0.0064 |
| 46 |
INJECTION SITE ULCER |
6 |
0.0064 |
| 47 |
TINEA INFECTION |
7 |
0.0063 |
| 48 |
HYPOMANIA |
23 |
0.0062 |
| 49 |
RHINITIS ALLERGIC |
27 |
0.0061 |
| 50 |
SEPSIS SYNDROME |
3 |
0.0060 |
| 51 |
SKIN CANDIDA |
3 |
0.0057 |
| 52 |
FREQUENT BOWEL MOVEMENTS |
153 |
0.0057 |
| 53 |
XEROSIS |
7 |
0.0057 |
| 54 |
LIP EROSION |
4 |
0.0055 |
| 55 |
LIFE EXPECTANCY SHORTENED |
3 |
0.0053 |
| 56 |
NASAL POLYPS |
26 |
0.0053 |
| 57 |
AORTIC CALCIFICATION |
3 |
0.0052 |
| 58 |
UPPER RESPIRATORY TRACT INFLAMMATION |
6 |
0.0050 |
| 59 |
PSEUDOMONAS TEST POSITIVE |
4 |
0.0049 |
| 60 |
SARCOIDOSIS |
23 |
0.0048 |
| 61 |
ENTEROVIRUS INFECTION |
4 |
0.0046 |
| 62 |
FINGER DEFORMITY |
22 |
0.0045 |
| 63 |
DYSLIPIDAEMIA |
23 |
0.0045 |
| 64 |
CANDIDA SEPSIS |
4 |
0.0045 |
| 65 |
LICHEN SCLEROSUS |
3 |
0.0044 |
| 66 |
CERUMEN IMPACTION |
4 |
0.0044 |
| 67 |
LEIOMYOMA |
3 |
0.0043 |
| 68 |
COLITIS |
161 |
0.0042 |
| 69 |
LANGUAGE DISORDER |
9 |
0.0042 |
| 70 |
OVERWEIGHT |
22 |
0.0041 |
| 71 |
BRONCHIECTASIS |
26 |
0.0039 |
| 72 |
RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS |
3 |
0.0038 |
| 73 |
MUSCLE DISCOMFORT |
3 |
0.0038 |
| 74 |
RECTAL HAEMORRHAGE |
163 |
0.0038 |
| 75 |
BRONCHOPULMONARY DYSPLASIA |
3 |
0.0037 |
| 76 |
DYSBIOSIS |
3 |
0.0037 |
| 77 |
GRANULOMA SKIN |
3 |
0.0037 |
| 78 |
SEPTIC EMBOLUS |
3 |
0.0036 |
| 79 |
RENAL CYST |
28 |
0.0035 |
| 80 |
COLITIS ULCERATIVE |
154 |
0.0034 |
| 81 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
3 |
0.0032 |
| 82 |
HYPOPROTEINAEMIA |
6 |
0.0032 |
| 83 |
KLEBSIELLA BACTERAEMIA |
3 |
0.0032 |
| 84 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
222 |
0.0031 |
| 85 |
HAEMATOCHEZIA |
172 |
0.0031 |
| 86 |
INFUSION RELATED REACTION |
206 |
0.0031 |
| 87 |
ACCIDENT |
36 |
0.0030 |
| 88 |
CARDIAC MURMUR |
26 |
0.0030 |
| 89 |
PURPURA |
26 |
0.0029 |
| 90 |
KIDNEY FIBROSIS |
5 |
0.0029 |
| 91 |
DECUBITUS ULCER |
23 |
0.0028 |
| 92 |
NEPHROPATHY |
26 |
0.0028 |
| 93 |
IMPETIGO |
4 |
0.0027 |
| 94 |
APLASTIC ANAEMIA |
14 |
0.0027 |
| 95 |
DYSAESTHESIA |
8 |
0.0026 |
| 96 |
PERIPHERAL EMBOLISM |
3 |
0.0026 |
| 97 |
RHINOVIRUS INFECTION |
10 |
0.0026 |
| 98 |
BICYTOPENIA |
5 |
0.0025 |
| 99 |
CHRONIC RESPIRATORY FAILURE |
3 |
0.0025 |
| 100 |
DEVICE RELATED SEPSIS |
5 |
0.0025 |
| 101 |
SKIN EROSION |
8 |
0.0025 |
| 102 |
MONOCYTE COUNT DECREASED |
3 |
0.0025 |
| 103 |
VASCULAR DEVICE INFECTION |
11 |
0.0024 |
| 104 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
11 |
0.0024 |
| 105 |
NEUROGENIC BLADDER |
5 |
0.0024 |
| 106 |
LUNG NEOPLASM |
10 |
0.0023 |
| 107 |
BODY HEIGHT DECREASED |
25 |
0.0023 |
| 108 |
MEAN CELL VOLUME INCREASED |
6 |
0.0023 |
| 109 |
PLATELET TRANSFUSION |
3 |
0.0023 |
| 110 |
ACUTE SINUSITIS |
4 |
0.0023 |
| 111 |
MESOTHELIOMA |
3 |
0.0023 |
| 112 |
BACTERIAL TEST POSITIVE |
5 |
0.0022 |
| 113 |
HAEMORRHOIDS |
43 |
0.0022 |
| 114 |
PNEUMONIA VIRAL |
7 |
0.0022 |
| 115 |
RHONCHI |
3 |
0.0022 |
| 116 |
DYSPEPSIA |
210 |
0.0021 |
| 117 |
PUSTULE |
5 |
0.0021 |
| 118 |
VOLVULUS |
5 |
0.0021 |
| 119 |
BODY TEMPERATURE INCREASED |
42 |
0.0021 |
| 120 |
SCHIZOPHRENIA |
25 |
0.0021 |
| 121 |
ILEUS PARALYTIC |
9 |
0.0020 |
| 122 |
BRONCHIOLITIS |
7 |
0.0020 |
| 123 |
PEMPHIGOID |
15 |
0.0020 |
| 124 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
3 |
0.0020 |
| 125 |
PARAINFLUENZAE VIRUS INFECTION |
3 |
0.0020 |
| 126 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
3 |
0.0020 |
| 127 |
CANCER PAIN |
5 |
0.0020 |
| 128 |
OVARIAN CANCER RECURRENT |
3 |
0.0019 |
| 129 |
PERIODONTITIS |
4 |
0.0018 |
| 130 |
OBESITY |
29 |
0.0018 |
| 131 |
CLOSTRIDIUM TEST POSITIVE |
4 |
0.0018 |
| 132 |
CHOLELITHIASIS |
59 |
0.0018 |
| 133 |
EROSIVE OESOPHAGITIS |
3 |
0.0018 |
| 134 |
BACTERAEMIA |
21 |
0.0018 |
| 135 |
SCIATICA |
28 |
0.0018 |
| 136 |
GRANULOMA |
6 |
0.0017 |
| 137 |
GASTROINTESTINAL NECROSIS |
5 |
0.0017 |
| 138 |
JOINT RANGE OF MOTION DECREASED |
23 |
0.0017 |
| 139 |
DISCOURAGEMENT |
4 |
0.0017 |
| 140 |
FANCONI SYNDROME ACQUIRED |
3 |
0.0017 |
| 141 |
FEBRILE NEUTROPENIA |
113 |
0.0017 |
| 142 |
ESCHERICHIA BACTERAEMIA |
4 |
0.0017 |
| 143 |
MALNUTRITION |
19 |
0.0017 |
| 144 |
PULMONARY TOXICITY |
12 |
0.0017 |
| 145 |
SPINAL COMPRESSION FRACTURE |
14 |
0.0017 |
| 146 |
PNEUMONIA ASPIRATION |
42 |
0.0017 |
| 147 |
METABOLIC ENCEPHALOPATHY |
5 |
0.0017 |
| 148 |
DISSEMINATED INTRAVASCULAR COAGULATION |
23 |
0.0016 |
| 149 |
DERMAL CYST |
4 |
0.0016 |
| 150 |
HYPERNATRAEMIA |
8 |
0.0016 |
| 151 |
HYPERPARATHYROIDISM SECONDARY |
4 |
0.0016 |
| 152 |
CATHETER SITE INFECTION |
6 |
0.0016 |
| 153 |
CUSHINGOID |
5 |
0.0016 |
| 154 |
LUNG OPACITY |
4 |
0.0015 |
| 155 |
HEPATIC STEATOSIS |
28 |
0.0015 |
| 156 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
13 |
0.0015 |
| 157 |
MUCOSAL DRYNESS |
3 |
0.0015 |
| 158 |
METASTASES TO SPINE |
5 |
0.0015 |
| 159 |
SKIN DISCOMFORT |
4 |
0.0015 |
| 160 |
DERMATITIS ACNEIFORM |
9 |
0.0015 |
| 161 |
IMMUNE-MEDIATED HEPATITIS |
3 |
0.0015 |
| 162 |
BLOOD BILIRUBIN INCREASED |
39 |
0.0014 |
| 163 |
HEPATOTOXICITY |
32 |
0.0014 |
| 164 |
PNEUMONIA BACTERIAL |
13 |
0.0014 |
| 165 |
DRUG ERUPTION |
25 |
0.0014 |
| 166 |
HAEMORRHAGE SUBCUTANEOUS |
5 |
0.0014 |
| 167 |
CATHETER SITE ERYTHEMA |
3 |
0.0014 |
| 168 |
HYPERPHOSPHATAEMIA |
3 |
0.0014 |
| 169 |
SYNOVITIS |
25 |
0.0014 |
| 170 |
ENTEROCOLITIS |
8 |
0.0014 |
| 171 |
HAEMOTHORAX |
4 |
0.0014 |
| 172 |
RALES |
8 |
0.0014 |
| 173 |
PARONYCHIA |
6 |
0.0014 |
| 174 |
NOSOCOMIAL INFECTION |
3 |
0.0014 |
| 175 |
GRAFT VERSUS HOST DISEASE IN SKIN |
3 |
0.0014 |
| 176 |
FOOT DEFORMITY |
15 |
0.0014 |
| 177 |
HEPATITIS FULMINANT |
4 |
0.0013 |
| 178 |
PSEUDOMEMBRANOUS COLITIS |
3 |
0.0013 |
| 179 |
CHRONIC GASTRITIS |
3 |
0.0013 |
| 180 |
MYELOFIBROSIS |
4 |
0.0013 |
| 181 |
REBOUND ACID HYPERSECRETION |
4 |
0.0013 |
| 182 |
RECTAL CANCER |
4 |
0.0013 |
| 183 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
4 |
0.0013 |
| 184 |
NEPHROGENIC ANAEMIA |
6 |
0.0013 |
| 185 |
ILEUS |
16 |
0.0013 |
| 186 |
HYPOALBUMINAEMIA |
10 |
0.0013 |
| 187 |
PSEUDOMONAS INFECTION |
11 |
0.0013 |
| 188 |
PULMONARY INFARCTION |
3 |
0.0013 |
| 189 |
ABDOMINAL ADHESIONS |
4 |
0.0013 |
| 190 |
ANAEMIA |
241 |
0.0013 |
| 191 |
LIMB INJURY |
34 |
0.0013 |
| 192 |
LYMPHADENITIS |
3 |
0.0012 |
| 193 |
HYPERAMMONAEMIA |
6 |
0.0012 |
| 194 |
KNEE ARTHROPLASTY |
25 |
0.0012 |
| 195 |
INCREASED BRONCHIAL SECRETION |
3 |
0.0012 |
| 196 |
PUSTULAR PSORIASIS |
4 |
0.0012 |
| 197 |
PYREXIA |
400 |
0.0012 |
| 198 |
FAILURE TO THRIVE |
6 |
0.0012 |
| 199 |
THROMBOPHLEBITIS |
4 |
0.0011 |
| 200 |
CLOSTRIDIUM DIFFICILE COLITIS |
12 |
0.0011 |
| 201 |
BREAST SWELLING |
3 |
0.0011 |
| 202 |
CHRONIC GRAFT VERSUS HOST DISEASE |
4 |
0.0011 |
| 203 |
EAR CONGESTION |
3 |
0.0011 |
| 204 |
GASTRIC PERFORATION |
3 |
0.0011 |
| 205 |
HYDROCEPHALUS |
6 |
0.0011 |
| 206 |
CONSTIPATION |
240 |
0.0011 |
| 207 |
BLOOD PHOSPHORUS INCREASED |
3 |
0.0011 |
| 208 |
HAEMOGLOBIN ABNORMAL |
7 |
0.0011 |
| 209 |
IMMUNE-MEDIATED ENTEROCOLITIS |
4 |
0.0011 |
| 210 |
HYPOPHOSPHATAEMIA |
8 |
0.0011 |
| 211 |
MACULE |
3 |
0.0011 |
| 212 |
ABDOMINAL PAIN |
251 |
0.0011 |
| 213 |
LUNG CONSOLIDATION |
3 |
0.0011 |
| 214 |
SKIN HYPERTROPHY |
3 |
0.0011 |
| 215 |
PNEUMATOSIS INTESTINALIS |
3 |
0.0011 |
| 216 |
DERMATITIS |
22 |
0.0010 |
| 217 |
DUODENAL ULCER HAEMORRHAGE |
3 |
0.0010 |
| 218 |
LIP PAIN |
3 |
0.0010 |
| 219 |
DEVICE RELATED INFECTION |
16 |
0.0010 |
| 220 |
ATELECTASIS |
10 |
0.0010 |
| 221 |
PNEUMONIA FUNGAL |
4 |
0.0010 |
| 222 |
HYPERVOLAEMIA |
5 |
0.0010 |
| 223 |
ARTHROPATHY |
56 |
0.0010 |
| 224 |
AZOTAEMIA |
4 |
0.0010 |
| 225 |
MOVEMENT DISORDER |
32 |
0.0010 |
| 226 |
JOINT STIFFNESS |
26 |
0.0010 |
| 227 |
FUNGAL SKIN INFECTION |
4 |
0.0010 |
| 228 |
MASTICATION DISORDER |
3 |
0.0010 |
| 229 |
HYPERURICAEMIA |
4 |
0.0010 |
| 230 |
CACHEXIA |
5 |
0.0010 |
| 231 |
PERIPHERAL VASCULAR DISORDER |
5 |
0.0010 |
| 232 |
BENIGN PROSTATIC HYPERPLASIA |
5 |
0.0010 |
| 233 |
CHOLANGITIS |
6 |
0.0010 |
| 234 |
WEIGHT DECREASED |
270 |
0.0010 |
| 235 |
OLIGURIA |
6 |
0.0010 |
| 236 |
SEPTIC SHOCK |
42 |
0.0010 |
| 237 |
RED CELL DISTRIBUTION WIDTH INCREASED |
4 |
0.0010 |
| 238 |
DYSSTASIA |
28 |
0.0010 |
| 239 |
BLOOD CREATININE DECREASED |
3 |
0.0010 |
| 240 |
ELECTROLYTE IMBALANCE |
11 |
0.0009 |
| 241 |
ERYTHEMA |
193 |
0.0009 |
| 242 |
LEFT VENTRICULAR HYPERTROPHY |
4 |
0.0009 |
| 243 |
COVID-19 PNEUMONIA |
11 |
0.0009 |
| 244 |
BACTERIAL SEPSIS |
3 |
0.0009 |
| 245 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 246 |
HEPATIC NEOPLASM |
3 |
0.0009 |
| 247 |
DIVERTICULUM INTESTINAL |
4 |
0.0009 |
| 248 |
HYPOGAMMAGLOBULINAEMIA |
6 |
0.0009 |
| 249 |
ONYCHOMYCOSIS |
4 |
0.0009 |
| 250 |
HAEMORRHAGIC ANAEMIA |
4 |
0.0009 |
| 251 |
HYPOXIA |
32 |
0.0009 |
| 252 |
OTITIS MEDIA |
3 |
0.0009 |
| 253 |
INTESTINAL ISCHAEMIA |
5 |
0.0009 |
| 254 |
CONGENITAL ANOMALY |
7 |
0.0009 |
| 255 |
CARDIAC FAILURE ACUTE |
6 |
0.0009 |
| 256 |
NEPHRITIS |
3 |
0.0009 |
| 257 |
SKIN INFECTION |
10 |
0.0009 |
| 258 |
HEPATIC CYST |
3 |
0.0009 |
| 259 |
HEPATIC ENZYME INCREASED |
60 |
0.0009 |
| 260 |
DRUG LEVEL ABOVE THERAPEUTIC |
4 |
0.0009 |
| 261 |
IRON DEFICIENCY ANAEMIA |
8 |
0.0009 |
| 262 |
MYASTHENIA GRAVIS |
7 |
0.0009 |
| 263 |
BLOOD URIC ACID INCREASED |
5 |
0.0009 |
| 264 |
ERYTHEMA MULTIFORME |
8 |
0.0009 |
| 265 |
ARTERIOSCLEROSIS |
8 |
0.0008 |
| 266 |
DECREASED INTEREST |
5 |
0.0008 |
| 267 |
HAEMORRHAGIC DIATHESIS |
3 |
0.0008 |
| 268 |
EOSINOPHIL COUNT INCREASED |
7 |
0.0008 |
| 269 |
LOWER RESPIRATORY TRACT INFECTION |
38 |
0.0008 |
| 270 |
SUBCUTANEOUS ABSCESS |
4 |
0.0008 |
| 271 |
LIVER DISORDER |
37 |
0.0008 |
| 272 |
HEPATIC FUNCTION ABNORMAL |
31 |
0.0008 |
| 273 |
MONOCYTE COUNT INCREASED |
3 |
0.0008 |
| 274 |
FOETAL GROWTH RESTRICTION |
5 |
0.0008 |
| 275 |
CUTANEOUS VASCULITIS |
3 |
0.0008 |
| 276 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
13 |
0.0008 |
| 277 |
ANURIA |
7 |
0.0008 |
| 278 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0008 |
| 279 |
SKIN DISORDER |
27 |
0.0008 |
| 280 |
ORGANISING PNEUMONIA |
4 |
0.0008 |
| 281 |
LEUKOENCEPHALOPATHY |
3 |
0.0008 |
| 282 |
OSTEOPOROSIS |
33 |
0.0008 |
| 283 |
PROTEIN TOTAL DECREASED |
3 |
0.0008 |
| 284 |
CORONARY ARTERY STENOSIS |
4 |
0.0008 |
| 285 |
PARANASAL SINUS DISCOMFORT |
3 |
0.0008 |
| 286 |
LYMPHOCYTE COUNT DECREASED |
14 |
0.0008 |
| 287 |
FACE INJURY |
3 |
0.0008 |
| 288 |
DERMATITIS CONTACT |
9 |
0.0008 |
| 289 |
SCAB |
9 |
0.0008 |
| 290 |
GASTRIC INFECTION |
3 |
0.0008 |
| 291 |
RENAL FAILURE CHRONIC |
6 |
0.0008 |
| 292 |
PSYCHOTIC DISORDER |
23 |
0.0008 |
| 293 |
VARICOSE VEIN |
4 |
0.0008 |
| 294 |
SEPSIS |
86 |
0.0008 |
| 295 |
PULMONARY HAEMORRHAGE |
6 |
0.0008 |
| 296 |
BONE DENSITY DECREASED |
24 |
0.0008 |
| 297 |
BLOOD ALBUMIN DECREASED |
6 |
0.0008 |
| 298 |
CORONAVIRUS INFECTION |
5 |
0.0008 |
| 299 |
OSTEOARTHRITIS |
32 |
0.0008 |
| 300 |
RESPIRATORY FAILURE |
55 |
0.0008 |
| 301 |
GASTROENTERITIS |
11 |
0.0008 |
| 302 |
HYPERLIPIDAEMIA |
9 |
0.0008 |
| 303 |
CEREBRAL ATROPHY |
3 |
0.0008 |
| 304 |
HEPATIC ENCEPHALOPATHY |
7 |
0.0007 |
| 305 |
BLEPHARITIS |
3 |
0.0007 |
| 306 |
CYTOKINE RELEASE SYNDROME |
15 |
0.0007 |
| 307 |
ANAL FISSURE |
4 |
0.0007 |
| 308 |
CYSTITIS HAEMORRHAGIC |
3 |
0.0007 |
| 309 |
ADRENAL INSUFFICIENCY |
9 |
0.0007 |
| 310 |
HYPOKALAEMIA |
34 |
0.0007 |
| 311 |
RECURRENT CANCER |
3 |
0.0007 |
| 312 |
OESOPHAGITIS |
8 |
0.0007 |
| 313 |
SUPRAVENTRICULAR TACHYCARDIA |
7 |
0.0007 |
| 314 |
ASPIRATION |
8 |
0.0007 |
| 315 |
ECCHYMOSIS |
5 |
0.0007 |
| 316 |
HYPERCALCAEMIA |
9 |
0.0007 |
| 317 |
PLEURAL EFFUSION |
44 |
0.0007 |
| 318 |
MALAISE |
317 |
0.0007 |
| 319 |
GASTRIC ULCER HAEMORRHAGE |
4 |
0.0007 |
| 320 |
STEVENS-JOHNSON SYNDROME |
16 |
0.0007 |
| 321 |
PSORIATIC ARTHROPATHY |
29 |
0.0007 |
| 322 |
RENAL TUBULAR NECROSIS |
7 |
0.0007 |
| 323 |
HYPERKALAEMIA |
25 |
0.0007 |
| 324 |
ACUTE PULMONARY OEDEMA |
4 |
0.0007 |
| 325 |
PAPULE |
5 |
0.0007 |
| 326 |
THERMAL BURN |
5 |
0.0007 |
| 327 |
CARDIAC FAILURE CHRONIC |
3 |
0.0007 |
| 328 |
PULMONARY TUBERCULOSIS |
3 |
0.0007 |
| 329 |
PURULENT DISCHARGE |
3 |
0.0007 |
| 330 |
SKIN ATROPHY |
4 |
0.0007 |
| 331 |
PNEUMOTHORAX |
11 |
0.0007 |
| 332 |
HYSTERECTOMY |
6 |
0.0007 |
| 333 |
PYELONEPHRITIS |
6 |
0.0007 |
| 334 |
RESPIRATORY DISTRESS |
19 |
0.0007 |
| 335 |
NEUTROPHIL COUNT DECREASED |
28 |
0.0007 |
| 336 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
16 |
0.0007 |
| 337 |
GASTRITIS |
18 |
0.0007 |
| 338 |
HYPOVOLAEMIA |
4 |
0.0007 |
| 339 |
GINGIVAL SWELLING |
3 |
0.0007 |
| 340 |
ABDOMINAL ABSCESS |
3 |
0.0007 |
| 341 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
4 |
0.0007 |
| 342 |
ARTHROPOD BITE |
5 |
0.0007 |
| 343 |
CELLULITIS |
34 |
0.0007 |
| 344 |
CYTOMEGALOVIRUS VIRAEMIA |
3 |
0.0007 |
| 345 |
RHEUMATIC FEVER |
3 |
0.0007 |
| 346 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
35 |
0.0007 |
| 347 |
METASTASES TO BONE |
11 |
0.0007 |
| 348 |
HYDRONEPHROSIS |
5 |
0.0007 |
| 349 |
GANGRENE |
4 |
0.0007 |
| 350 |
END STAGE RENAL DISEASE |
12 |
0.0007 |
| 351 |
INGUINAL HERNIA |
4 |
0.0007 |
| 352 |
LUNG NEOPLASM MALIGNANT |
27 |
0.0007 |
| 353 |
HYPONATRAEMIA |
37 |
0.0007 |
| 354 |
CANDIDA INFECTION |
11 |
0.0007 |
| 355 |
EYE OPERATION |
3 |
0.0007 |
| 356 |
ASCITES |
19 |
0.0006 |
| 357 |
BRONCHOPULMONARY ASPERGILLOSIS |
5 |
0.0006 |
| 358 |
INTERSTITIAL LUNG DISEASE |
31 |
0.0006 |
| 359 |
SWELLING OF EYELID |
4 |
0.0006 |
| 360 |
PRODUCT USE COMPLAINT |
10 |
0.0006 |
| 361 |
DELIRIUM |
22 |
0.0006 |
| 362 |
OBSTRUCTIVE AIRWAYS DISORDER |
7 |
0.0006 |
| 363 |
OEDEMA |
34 |
0.0006 |
| 364 |
NON-SMALL CELL LUNG CANCER |
3 |
0.0006 |
| 365 |
ORAL PAIN |
14 |
0.0006 |
| 366 |
NEUTROPENIA |
85 |
0.0006 |
| 367 |
HUMERUS FRACTURE |
3 |
0.0006 |
| 368 |
HYPERCHOLESTEROLAEMIA |
6 |
0.0006 |
| 369 |
ENTEROCOCCAL INFECTION |
3 |
0.0006 |
| 370 |
RASH VESICULAR |
3 |
0.0006 |
| 371 |
BLOOD POTASSIUM INCREASED |
10 |
0.0006 |
| 372 |
HAEMORRHOIDAL HAEMORRHAGE |
3 |
0.0006 |
| 373 |
RENAL CELL CARCINOMA |
3 |
0.0006 |
| 374 |
GASTROOESOPHAGEAL REFLUX DISEASE |
49 |
0.0006 |
| 375 |
BEDRIDDEN |
8 |
0.0006 |
| 376 |
PULMONARY CONGESTION |
8 |
0.0006 |
| 377 |
PERICARDIAL EFFUSION |
14 |
0.0006 |
| 378 |
HAEMATOCRIT DECREASED |
12 |
0.0006 |
| 379 |
C-REACTIVE PROTEIN INCREASED |
22 |
0.0006 |
| 380 |
DIABETES MELLITUS |
46 |
0.0006 |
| 381 |
ALANINE AMINOTRANSFERASE INCREASED |
37 |
0.0006 |
| 382 |
ASPARTATE AMINOTRANSFERASE INCREASED |
32 |
0.0006 |
| 383 |
PRESCRIBED UNDERDOSE |
12 |
0.0006 |
| 384 |
FLUID INTAKE REDUCED |
3 |
0.0006 |
| 385 |
WHITE BLOOD CELL COUNT INCREASED |
23 |
0.0006 |
| 386 |
ERYSIPELAS |
3 |
0.0006 |
| 387 |
TOXIC SKIN ERUPTION |
6 |
0.0006 |
| 388 |
KLEBSIELLA INFECTION |
3 |
0.0006 |
| 389 |
CONJUNCTIVITIS |
11 |
0.0006 |
| 390 |
METASTASES TO LYMPH NODES |
4 |
0.0006 |
| 391 |
MUSCULOSKELETAL PAIN |
31 |
0.0006 |
| 392 |
PATHOLOGICAL FRACTURE |
3 |
0.0006 |
| 393 |
TACHYPNOEA |
8 |
0.0006 |
| 394 |
HYPOPHAGIA |
15 |
0.0006 |
| 395 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
13 |
0.0006 |
| 396 |
EYE MOVEMENT DISORDER |
4 |
0.0006 |
| 397 |
CEREBRAL ISCHAEMIA |
3 |
0.0006 |
| 398 |
ACUTE MYELOID LEUKAEMIA |
9 |
0.0006 |
| 399 |
LARGE INTESTINE POLYP |
4 |
0.0006 |
| 400 |
THERAPY PARTIAL RESPONDER |
9 |
0.0006 |
| 401 |
TRANSFUSION |
6 |
0.0006 |
| 402 |
ACUTE RESPIRATORY FAILURE |
11 |
0.0006 |
| 403 |
URINARY RETENTION |
19 |
0.0006 |
| 404 |
CARDIOMEGALY |
7 |
0.0006 |
| 405 |
TUMOUR LYSIS SYNDROME |
5 |
0.0006 |
| 406 |
INCONTINENCE |
6 |
0.0006 |
| 407 |
DUODENAL ULCER |
4 |
0.0006 |
| 408 |
LUNG INFILTRATION |
5 |
0.0006 |
| 409 |
ULCER |
9 |
0.0006 |
| 410 |
ANORECTAL DISCOMFORT |
3 |
0.0006 |
| 411 |
HEPATIC FAILURE |
17 |
0.0006 |
| 412 |
GASTROINTESTINAL MOTILITY DISORDER |
3 |
0.0006 |
| 413 |
FOOD POISONING |
3 |
0.0006 |
| 414 |
OEDEMA PERIPHERAL |
68 |
0.0006 |
| 415 |
ANAL ABSCESS |
3 |
0.0006 |
| 416 |
WHEEZING |
33 |
0.0006 |
| 417 |
ERYTHEMA OF EYELID |
3 |
0.0006 |
| 418 |
VISUAL FIELD DEFECT |
4 |
0.0006 |
| 419 |
DERMATITIS BULLOUS |
4 |
0.0006 |
| 420 |
PNEUMONITIS |
15 |
0.0006 |
| 421 |
FAECALOMA |
3 |
0.0005 |
| 422 |
FLATULENCE |
31 |
0.0005 |
| 423 |
MOUTH HAEMORRHAGE |
4 |
0.0005 |
| 424 |
GASTROINTESTINAL PAIN |
6 |
0.0005 |
| 425 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
6 |
0.0005 |
| 426 |
BONE MARROW FAILURE |
11 |
0.0005 |
| 427 |
HAEMOPTYSIS |
15 |
0.0005 |
| 428 |
BLOOD UREA INCREASED |
9 |
0.0005 |
| 429 |
PULMONARY MASS |
8 |
0.0005 |
| 430 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 431 |
CEREBRAL INFARCTION |
13 |
0.0005 |
| 432 |
SPINAL DISORDER |
5 |
0.0005 |
| 433 |
TOXIC EPIDERMAL NECROLYSIS |
8 |
0.0005 |
| 434 |
TROPONIN INCREASED |
4 |
0.0005 |
| 435 |
HAEMATURIA |
18 |
0.0005 |
| 436 |
PAIN |
322 |
0.0005 |
| 437 |
ACIDOSIS |
4 |
0.0005 |
| 438 |
BOWEL MOVEMENT IRREGULARITY |
4 |
0.0005 |
| 439 |
HYPERGLYCAEMIA |
19 |
0.0005 |
| 440 |
HERPES VIRUS INFECTION |
3 |
0.0005 |
| 441 |
EATING DISORDER |
11 |
0.0005 |
| 442 |
HYPOGLYCAEMIA |
25 |
0.0005 |
| 443 |
STAPHYLOCOCCAL INFECTION |
17 |
0.0005 |
| 444 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
4 |
0.0005 |
| 445 |
PULMONARY OEDEMA |
23 |
0.0005 |
| 446 |
IRRITABLE BOWEL SYNDROME |
11 |
0.0005 |
| 447 |
PNEUMONIA |
166 |
0.0005 |
| 448 |
HAEMORRHAGIC STROKE |
4 |
0.0005 |
| 449 |
SKIN FISSURES |
10 |
0.0005 |
| 450 |
ELECTROCARDIOGRAM ABNORMAL |
4 |
0.0005 |
| 451 |
DECREASED IMMUNE RESPONSIVENESS |
5 |
0.0005 |
| 452 |
AFFECTIVE DISORDER |
4 |
0.0005 |
| 453 |
BLOOD CREATININE INCREASED |
33 |
0.0005 |
| 454 |
FURUNCLE |
4 |
0.0005 |
| 455 |
CHOLECYSTITIS |
6 |
0.0005 |
| 456 |
HYPOMAGNESAEMIA |
7 |
0.0005 |
| 457 |
BLOOD TEST ABNORMAL |
7 |
0.0005 |
| 458 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
5 |
0.0005 |
| 459 |
LEUKOCYTOSIS |
9 |
0.0005 |
| 460 |
PLATELET COUNT DECREASED |
53 |
0.0005 |
| 461 |
MUCOSAL INFLAMMATION |
13 |
0.0005 |
| 462 |
EMPHYSEMA |
5 |
0.0005 |
| 463 |
STOMATITIS |
30 |
0.0005 |
| 464 |
TASTE DISORDER |
10 |
0.0005 |
| 465 |
INTENTIONAL PRODUCT MISUSE |
43 |
0.0005 |
| 466 |
SUBARACHNOID HAEMORRHAGE |
5 |
0.0005 |
| 467 |
SUBDURAL HAEMATOMA |
7 |
0.0005 |
| 468 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
5 |
0.0005 |
| 469 |
CONCOMITANT DISEASE AGGRAVATED |
3 |
0.0005 |
| 470 |
PIGMENTATION DISORDER |
3 |
0.0005 |
| 471 |
POOR VENOUS ACCESS |
5 |
0.0005 |
| 472 |
BACTERIAL INFECTION |
9 |
0.0005 |
| 473 |
BACK PAIN |
112 |
0.0005 |
| 474 |
INFUSION SITE SWELLING |
3 |
0.0005 |
| 475 |
PROTEINURIA |
9 |
0.0005 |
| 476 |
NAUSEA |
372 |
0.0005 |
| 477 |
IMMUNODEFICIENCY |
7 |
0.0005 |
| 478 |
MENTAL STATUS CHANGES |
13 |
0.0005 |
| 479 |
C-REACTIVE PROTEIN ABNORMAL |
3 |
0.0005 |
| 480 |
DEMENTIA |
13 |
0.0005 |
| 481 |
ERUCTATION |
9 |
0.0005 |
| 482 |
OFF LABEL USE |
404 |
0.0005 |
| 483 |
CHILLS |
54 |
0.0005 |
| 484 |
SKIN LACERATION |
5 |
0.0005 |
| 485 |
DEHYDRATION |
61 |
0.0005 |
| 486 |
INTERNATIONAL NORMALISED RATIO INCREASED |
13 |
0.0005 |
| 487 |
TOOTH INFECTION |
6 |
0.0005 |
| 488 |
ARTERIOSCLEROSIS CORONARY ARTERY |
3 |
0.0005 |
| 489 |
APPETITE DISORDER |
3 |
0.0005 |
| 490 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
13 |
0.0005 |
| 491 |
VENTRICULAR FIBRILLATION |
5 |
0.0004 |
| 492 |
SKIN MASS |
3 |
0.0004 |
| 493 |
ATRIOVENTRICULAR BLOCK COMPLETE |
3 |
0.0004 |
| 494 |
PRODUCT ADMINISTRATION ERROR |
9 |
0.0004 |
| 495 |
CYANOSIS |
7 |
0.0004 |
| 496 |
PANCREATITIS ACUTE |
10 |
0.0004 |
| 497 |
ANAL INCONTINENCE |
4 |
0.0004 |
| 498 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
11 |
0.0004 |
| 499 |
MITRAL VALVE INCOMPETENCE |
5 |
0.0004 |
| 500 |
ABDOMINAL DISTENSION |
46 |
0.0004 |
| 501 |
IMPAIRED GASTRIC EMPTYING |
6 |
0.0004 |
| 502 |
ACUTE HEPATIC FAILURE |
6 |
0.0004 |
| 503 |
ACUTE KIDNEY INJURY |
67 |
0.0004 |
| 504 |
HERPES ZOSTER |
25 |
0.0004 |
| 505 |
SHOCK |
10 |
0.0004 |
| 506 |
RESPIRATORY DISORDER |
13 |
0.0004 |
| 507 |
DROOLING |
3 |
0.0004 |
| 508 |
WOUND |
12 |
0.0004 |
| 509 |
DRUG INEFFECTIVE |
565 |
0.0004 |
| 510 |
APPENDICITIS |
4 |
0.0004 |
| 511 |
RIGHT VENTRICULAR FAILURE |
3 |
0.0004 |
| 512 |
DEFORMITY |
4 |
0.0004 |
| 513 |
VOMITING |
201 |
0.0004 |
| 514 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
11 |
0.0004 |
| 515 |
FLANK PAIN |
4 |
0.0004 |
| 516 |
ANAPHYLACTIC SHOCK |
11 |
0.0004 |
| 517 |
SKIN ULCER |
11 |
0.0004 |
| 518 |
DYSPNOEA EXERTIONAL |
16 |
0.0004 |
| 519 |
SINUS TACHYCARDIA |
6 |
0.0004 |
| 520 |
DIVERTICULUM |
3 |
0.0004 |
| 521 |
URINARY TRACT INFECTION |
72 |
0.0004 |
| 522 |
DECREASED APPETITE |
98 |
0.0004 |
| 523 |
BLOOD URINE PRESENT |
8 |
0.0004 |
| 524 |
FUNGAL INFECTION |
14 |
0.0004 |
| 525 |
ARTHRITIS |
33 |
0.0004 |
| 526 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
4 |
0.0004 |
| 527 |
CARDIOGENIC SHOCK |
6 |
0.0004 |
| 528 |
IMPAIRED QUALITY OF LIFE |
6 |
0.0004 |
| 529 |
LETHARGY |
24 |
0.0004 |
| 530 |
ALTERED STATE OF CONSCIOUSNESS |
9 |
0.0004 |
| 531 |
FAECES SOFT |
3 |
0.0004 |
| 532 |
RASH PUSTULAR |
3 |
0.0004 |
| 533 |
PANCYTOPENIA |
23 |
0.0004 |
| 534 |
AUTOIMMUNE DISORDER |
4 |
0.0004 |
| 535 |
BLOOD PRESSURE SYSTOLIC INCREASED |
8 |
0.0004 |
| 536 |
MELAENA |
9 |
0.0004 |
| 537 |
CYTOPENIA |
5 |
0.0004 |
| 538 |
ENCEPHALOPATHY |
10 |
0.0004 |
| 539 |
HEPATOMEGALY |
4 |
0.0004 |
| 540 |
RENAL FAILURE |
54 |
0.0004 |
| 541 |
CARDIOMYOPATHY |
6 |
0.0004 |
| 542 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
16 |
0.0004 |
| 543 |
GENERALISED OEDEMA |
5 |
0.0004 |
| 544 |
PHARYNGITIS |
5 |
0.0004 |
| 545 |
TOOTH EXTRACTION |
5 |
0.0004 |
| 546 |
ECZEMA |
21 |
0.0004 |
| 547 |
HAEMOGLOBIN DECREASED |
41 |
0.0004 |
| 548 |
BREAST TENDERNESS |
3 |
0.0004 |
| 549 |
INTESTINAL OBSTRUCTION |
15 |
0.0004 |
| 550 |
PAROSMIA |
3 |
0.0004 |
| 551 |
IMPAIRED HEALING |
13 |
0.0004 |
| 552 |
BRAIN OEDEMA |
5 |
0.0004 |
| 553 |
LYMPHADENOPATHY |
14 |
0.0004 |
| 554 |
FEELING COLD |
11 |
0.0004 |
| 555 |
HYPOTHERMIA |
4 |
0.0004 |
| 556 |
MUSCLE ATROPHY |
5 |
0.0004 |
| 557 |
HEPATOCELLULAR CARCINOMA |
3 |
0.0004 |
| 558 |
SLUGGISHNESS |
4 |
0.0004 |
| 559 |
DIARRHOEA |
252 |
0.0004 |
| 560 |
DIFFUSE LARGE B-CELL LYMPHOMA |
3 |
0.0004 |
| 561 |
MUSCULOSKELETAL STIFFNESS |
34 |
0.0004 |
| 562 |
APHTHOUS ULCER |
3 |
0.0004 |
| 563 |
HIATUS HERNIA |
5 |
0.0004 |
| 564 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 565 |
VENTRICULAR EXTRASYSTOLES |
4 |
0.0004 |
| 566 |
RESPIRATORY TRACT INFECTION |
10 |
0.0004 |
| 567 |
PETECHIAE |
4 |
0.0004 |
| 568 |
WEIGHT FLUCTUATION |
4 |
0.0004 |
| 569 |
SARS-COV-2 TEST POSITIVE |
5 |
0.0004 |
| 570 |
WHITE BLOOD CELL COUNT DECREASED |
41 |
0.0004 |
| 571 |
FULL BLOOD COUNT ABNORMAL |
4 |
0.0004 |
| 572 |
HEADACHE |
237 |
0.0004 |
| 573 |
HYPERTENSION |
80 |
0.0004 |
| 574 |
RENAL PAIN |
4 |
0.0004 |
| 575 |
GINGIVAL PAIN |
3 |
0.0004 |
| 576 |
ATRIAL FLUTTER |
3 |
0.0004 |
| 577 |
JOINT INJURY |
8 |
0.0004 |
| 578 |
CARDIAC FAILURE |
30 |
0.0004 |
| 579 |
OXYGEN SATURATION DECREASED |
21 |
0.0004 |
| 580 |
BREAST CANCER METASTATIC |
4 |
0.0004 |
| 581 |
RHINITIS |
3 |
0.0004 |
| 582 |
URINARY INCONTINENCE |
11 |
0.0004 |
| 583 |
MUSCLE DISORDER |
3 |
0.0004 |
| 584 |
FIBROMYALGIA |
9 |
0.0004 |
| 585 |
HYPOCALCAEMIA |
7 |
0.0004 |
| 586 |
CHRONIC KIDNEY DISEASE |
28 |
0.0004 |
| 587 |
UPPER RESPIRATORY TRACT INFECTION |
17 |
0.0004 |
| 588 |
ABNORMAL FAECES |
3 |
0.0004 |
| 589 |
HICCUPS |
3 |
0.0004 |
| 590 |
SKIN LESION |
10 |
0.0004 |
| 591 |
SEROTONIN SYNDROME |
7 |
0.0004 |
| 592 |
PERIPHERAL COLDNESS |
5 |
0.0004 |
| 593 |
SEIZURE |
42 |
0.0004 |
| 594 |
CEREBRAL HAEMORRHAGE |
13 |
0.0004 |
| 595 |
DENTAL CARIES |
4 |
0.0004 |
| 596 |
CYTOMEGALOVIRUS INFECTION |
6 |
0.0004 |
| 597 |
HEMIPLEGIA |
3 |
0.0004 |
| 598 |
DRUG ABUSE |
30 |
0.0004 |
| 599 |
EAR PAIN |
7 |
0.0004 |
| 600 |
MASS |
5 |
0.0004 |
| 601 |
RENAL IMPAIRMENT |
30 |
0.0004 |
| 602 |
INTESTINAL PERFORATION |
4 |
0.0004 |
| 603 |
STATUS EPILEPTICUS |
4 |
0.0004 |
| 604 |
DYSURIA |
13 |
0.0004 |
| 605 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
10 |
0.0004 |
| 606 |
BLOOD PRESSURE ABNORMAL |
7 |
0.0004 |
| 607 |
BRONCHITIS |
26 |
0.0004 |
| 608 |
DRUG-INDUCED LIVER INJURY |
11 |
0.0004 |
| 609 |
INTERNAL HAEMORRHAGE |
4 |
0.0003 |
| 610 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
6 |
0.0003 |
| 611 |
ANGINA PECTORIS |
10 |
0.0003 |
| 612 |
THROMBOCYTOPENIA |
39 |
0.0003 |
| 613 |
NEOPLASM |
4 |
0.0003 |
| 614 |
GASTRIC HAEMORRHAGE |
4 |
0.0003 |
| 615 |
MYOPATHY |
3 |
0.0003 |
| 616 |
METASTASES TO LUNG |
4 |
0.0003 |
| 617 |
HYPOKINESIA |
5 |
0.0003 |
| 618 |
DEAFNESS |
9 |
0.0003 |
| 619 |
BLOOD CALCIUM INCREASED |
3 |
0.0003 |
| 620 |
NIGHT SWEATS |
11 |
0.0003 |
| 621 |
DRY EYE |
17 |
0.0003 |
| 622 |
ABDOMINAL DISCOMFORT |
57 |
0.0003 |
| 623 |
GAIT DISTURBANCE |
65 |
0.0003 |
| 624 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
3 |
0.0003 |
| 625 |
HEAD DISCOMFORT |
6 |
0.0003 |
| 626 |
DEEP VEIN THROMBOSIS |
22 |
0.0003 |
| 627 |
PERITONITIS |
7 |
0.0003 |
| 628 |
BLOOD IRON DECREASED |
4 |
0.0003 |
| 629 |
PULMONARY HYPERTENSION |
7 |
0.0003 |
| 630 |
HAEMOLYTIC ANAEMIA |
3 |
0.0003 |
| 631 |
RASH ERYTHEMATOUS |
16 |
0.0003 |
| 632 |
GASTROINTESTINAL INFECTION |
3 |
0.0003 |
| 633 |
HAEMORRHAGE INTRACRANIAL |
5 |
0.0003 |
| 634 |
PAIN OF SKIN |
9 |
0.0003 |
| 635 |
TOOTHACHE |
6 |
0.0003 |
| 636 |
OSTEOMYELITIS |
6 |
0.0003 |
| 637 |
VIRAL INFECTION |
11 |
0.0003 |
| 638 |
BURSITIS |
4 |
0.0003 |
| 639 |
RETCHING |
7 |
0.0003 |
| 640 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
3 |
0.0003 |
| 641 |
MUSCLE SPASTICITY |
4 |
0.0003 |
| 642 |
OVARIAN CANCER |
3 |
0.0003 |
| 643 |
DIVERTICULITIS |
9 |
0.0003 |
| 644 |
OSTEONECROSIS OF JAW |
8 |
0.0003 |
| 645 |
INJECTION SITE DISCOLOURATION |
4 |
0.0003 |
| 646 |
GENERAL PHYSICAL HEALTH DETERIORATION |
37 |
0.0003 |
| 647 |
SECRETION DISCHARGE |
4 |
0.0003 |
| 648 |
TRANSAMINASES INCREASED |
7 |
0.0003 |
| 649 |
CYSTITIS |
10 |
0.0003 |
| 650 |
INFLUENZA |
35 |
0.0003 |
| 651 |
BURNING SENSATION |
22 |
0.0003 |
| 652 |
ABSCESS |
5 |
0.0003 |
| 653 |
GASTROINTESTINAL HAEMORRHAGE |
26 |
0.0003 |
| 654 |
SINUS BRADYCARDIA |
3 |
0.0003 |
| 655 |
LIVER FUNCTION TEST ABNORMAL |
9 |
0.0003 |
| 656 |
RHINORRHOEA |
20 |
0.0003 |
| 657 |
DIZZINESS POSTURAL |
3 |
0.0003 |
| 658 |
PARKINSONISM |
3 |
0.0003 |
| 659 |
ORAL HERPES |
6 |
0.0003 |
| 660 |
KIDNEY INFECTION |
6 |
0.0003 |
| 661 |
SPEECH DISORDER |
16 |
0.0003 |
| 662 |
HOSPICE CARE |
3 |
0.0003 |
| 663 |
LIGAMENT SPRAIN |
3 |
0.0003 |
| 664 |
GENERALISED TONIC-CLONIC SEIZURE |
5 |
0.0003 |
| 665 |
BLOOD PRESSURE DECREASED |
20 |
0.0003 |
| 666 |
COAGULOPATHY |
5 |
0.0003 |
| 667 |
ATRIAL FIBRILLATION |
29 |
0.0003 |
| 668 |
FACE OEDEMA |
5 |
0.0003 |
| 669 |
FEEDING DISORDER |
6 |
0.0003 |
| 670 |
DYSPHAGIA |
28 |
0.0003 |
| 671 |
PALLOR |
8 |
0.0003 |
| 672 |
MALIGNANT NEOPLASM PROGRESSION |
30 |
0.0003 |
| 673 |
CONDITION AGGRAVATED |
89 |
0.0003 |
| 674 |
OROPHARYNGEAL PAIN |
27 |
0.0003 |
| 675 |
PSORIASIS |
38 |
0.0003 |
| 676 |
FEMUR FRACTURE |
9 |
0.0003 |
| 677 |
SKELETAL INJURY |
3 |
0.0003 |
| 678 |
EYE DISCHARGE |
3 |
0.0003 |
| 679 |
NERVOUS SYSTEM DISORDER |
9 |
0.0003 |
| 680 |
NEURALGIA |
7 |
0.0003 |
| 681 |
ASTHENIA |
108 |
0.0003 |
| 682 |
ORTHOSTATIC HYPOTENSION |
5 |
0.0003 |
| 683 |
CARDIAC FAILURE CONGESTIVE |
23 |
0.0003 |
| 684 |
LIVER INJURY |
7 |
0.0003 |
| 685 |
MOUTH ULCERATION |
6 |
0.0003 |
| 686 |
METASTASES TO LIVER |
5 |
0.0003 |
| 687 |
SKIN REACTION |
4 |
0.0003 |
| 688 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
5 |
0.0003 |
| 689 |
RASH |
123 |
0.0003 |
| 690 |
METABOLIC ACIDOSIS |
9 |
0.0003 |
| 691 |
TACHYCARDIA |
25 |
0.0003 |
| 692 |
THIRST |
5 |
0.0003 |
| 693 |
LIVER FUNCTION TEST INCREASED |
6 |
0.0003 |
| 694 |
PARALYSIS |
4 |
0.0003 |
| 695 |
COVID-19 |
49 |
0.0003 |
| 696 |
BLOOD CHOLESTEROL INCREASED |
13 |
0.0003 |
| 697 |
CARDIAC ARREST |
23 |
0.0003 |
| 698 |
PRURITUS GENERALISED |
6 |
0.0003 |
| 699 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
50 |
0.0003 |
| 700 |
FAECES DISCOLOURED |
6 |
0.0003 |
| 701 |
MYELODYSPLASTIC SYNDROME |
4 |
0.0003 |
| 702 |
GASTRIC CANCER |
7 |
0.0003 |
| 703 |
HYPERTHYROIDISM |
4 |
0.0003 |
| 704 |
HAEMATEMESIS |
7 |
0.0003 |
| 705 |
CLOSTRIDIUM DIFFICILE INFECTION |
6 |
0.0003 |
| 706 |
PANIC ATTACK |
10 |
0.0003 |
| 707 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 708 |
HAEMATOMA |
7 |
0.0003 |
| 709 |
SKIN HAEMORRHAGE |
4 |
0.0003 |
| 710 |
RASH MACULO-PAPULAR |
6 |
0.0003 |
| 711 |
DIPLOPIA |
7 |
0.0003 |
| 712 |
AGRANULOCYTOSIS |
5 |
0.0003 |
| 713 |
EYE SWELLING |
10 |
0.0003 |
| 714 |
COLON CANCER |
4 |
0.0003 |
| 715 |
HEART RATE IRREGULAR |
6 |
0.0003 |
| 716 |
APHASIA |
8 |
0.0003 |
| 717 |
FALL |
88 |
0.0003 |
| 718 |
MUSCULAR WEAKNESS |
30 |
0.0003 |
| 719 |
MYOCARDIAL ISCHAEMIA |
3 |
0.0003 |
| 720 |
OSTEOPENIA |
4 |
0.0003 |
| 721 |
PRODUCT AVAILABILITY ISSUE |
6 |
0.0003 |
| 722 |
SLEEP APNOEA SYNDROME |
5 |
0.0003 |
| 723 |
EPILEPSY |
8 |
0.0003 |
| 724 |
CHOLESTASIS |
5 |
0.0003 |
| 725 |
GLAUCOMA |
5 |
0.0003 |
| 726 |
HERNIA |
5 |
0.0003 |
| 727 |
EYELID OEDEMA |
3 |
0.0003 |
| 728 |
CHOKING |
5 |
0.0003 |
| 729 |
HYPOTENSION |
51 |
0.0003 |
| 730 |
EPISTAXIS |
19 |
0.0003 |
| 731 |
PULMONARY EMBOLISM |
24 |
0.0003 |
| 732 |
INFLAMMATION |
13 |
0.0003 |
| 733 |
MYOCLONUS |
3 |
0.0003 |
| 734 |
MUSCLE RIGIDITY |
3 |
0.0003 |
| 735 |
SPINAL FRACTURE |
5 |
0.0002 |
| 736 |
BLISTER |
14 |
0.0002 |
| 737 |
SKIN EXFOLIATION |
21 |
0.0002 |
| 738 |
INFECTION |
36 |
0.0002 |
| 739 |
PANCREATITIS |
13 |
0.0002 |
| 740 |
LUNG DISORDER |
12 |
0.0002 |
| 741 |
HYPERSOMNIA |
7 |
0.0002 |
| 742 |
RIB FRACTURE |
5 |
0.0002 |
| 743 |
DRUG LEVEL INCREASED |
4 |
0.0002 |
| 744 |
PSYCHOMOTOR HYPERACTIVITY |
4 |
0.0002 |
| 745 |
RHABDOMYOLYSIS |
10 |
0.0002 |
| 746 |
POLLAKIURIA |
10 |
0.0002 |
| 747 |
DERMATITIS ALLERGIC |
3 |
0.0002 |
| 748 |
PRODUCT DOSE OMISSION ISSUE |
70 |
0.0002 |
| 749 |
ACUTE MYOCARDIAL INFARCTION |
7 |
0.0002 |
| 750 |
RENAL FAILURE ACUTE |
10 |
0.0002 |
| 751 |
GENITAL HAEMORRHAGE |
3 |
0.0002 |
| 752 |
CHEST PAIN |
43 |
0.0002 |
| 753 |
MULTI-ORGAN FAILURE |
4 |
0.0002 |
| 754 |
SEDATION |
6 |
0.0002 |
| 755 |
NEUROTOXICITY |
4 |
0.0002 |
| 756 |
AMENORRHOEA |
4 |
0.0002 |
| 757 |
IMMUNE SYSTEM DISORDER |
3 |
0.0002 |
| 758 |
BLOOD TRIGLYCERIDES INCREASED |
4 |
0.0002 |
| 759 |
BRADYCARDIA |
12 |
0.0002 |
| 760 |
DIABETES MELLITUS INADEQUATE CONTROL |
4 |
0.0002 |
| 761 |
HAIR TEXTURE ABNORMAL |
3 |
0.0002 |
| 762 |
MYELOSUPPRESSION |
8 |
0.0002 |
| 763 |
BONE PAIN |
13 |
0.0002 |
| 764 |
NEUROPATHY PERIPHERAL |
21 |
0.0002 |
| 765 |
DISEASE PROGRESSION |
26 |
0.0002 |
| 766 |
BONE DISORDER |
4 |
0.0002 |
| 767 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 768 |
ARTHRALGIA |
91 |
0.0002 |
| 769 |
LOSS OF CONSCIOUSNESS |
28 |
0.0002 |
| 770 |
RESPIRATORY ARREST |
6 |
0.0002 |
| 771 |
CONFUSIONAL STATE |
35 |
0.0002 |
| 772 |
LACTIC ACIDOSIS |
7 |
0.0002 |
| 773 |
MEDICATION ERROR |
12 |
0.0002 |
| 774 |
ORAL DISCOMFORT |
3 |
0.0002 |
| 775 |
CARDIO-RESPIRATORY ARREST |
9 |
0.0002 |
| 776 |
RENAL DISORDER |
10 |
0.0002 |
| 777 |
ABDOMINAL PAIN UPPER |
44 |
0.0002 |
| 778 |
DEVICE OCCLUSION |
3 |
0.0002 |
| 779 |
DYSARTHRIA |
8 |
0.0002 |
| 780 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 781 |
LYMPHOPENIA |
3 |
0.0002 |
| 782 |
INTENTIONAL DOSE OMISSION |
6 |
0.0002 |
| 783 |
BRONCHOSPASM |
3 |
0.0002 |
| 784 |
DERMATITIS ATOPIC |
11 |
0.0002 |
| 785 |
OVERDOSE |
45 |
0.0002 |
| 786 |
BLOOD PRESSURE FLUCTUATION |
5 |
0.0002 |
| 787 |
POST PROCEDURAL COMPLICATION |
4 |
0.0002 |
| 788 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 789 |
PRESCRIBED OVERDOSE |
4 |
0.0002 |
| 790 |
COMPLICATION ASSOCIATED WITH DEVICE |
3 |
0.0002 |
| 791 |
RENAL INJURY |
6 |
0.0002 |
| 792 |
SINUS DISORDER |
4 |
0.0002 |
| 793 |
DISORIENTATION |
8 |
0.0002 |
| 794 |
CATARACT |
12 |
0.0002 |
| 795 |
THERAPY NON-RESPONDER |
9 |
0.0002 |
| 796 |
SYNCOPE |
20 |
0.0002 |
| 797 |
BLOOD POTASSIUM DECREASED |
6 |
0.0002 |
| 798 |
HYPOAESTHESIA ORAL |
3 |
0.0002 |
| 799 |
DEVICE FAILURE |
3 |
0.0002 |
| 800 |
DYSKINESIA |
8 |
0.0002 |
| 801 |
DISCOMFORT |
12 |
0.0002 |
| 802 |
NEPHROLITHIASIS |
9 |
0.0002 |
| 803 |
INSOMNIA |
52 |
0.0002 |
| 804 |
NEOPLASM MALIGNANT |
13 |
0.0002 |
| 805 |
ERECTILE DYSFUNCTION |
5 |
0.0002 |
| 806 |
UNDERDOSE |
14 |
0.0002 |
| 807 |
PRURITUS |
73 |
0.0002 |
| 808 |
NASOPHARYNGITIS |
35 |
0.0002 |
| 809 |
GASTROINTESTINAL DISORDER |
17 |
0.0002 |
| 810 |
HALLUCINATION, VISUAL |
4 |
0.0002 |
| 811 |
RESPIRATORY TRACT CONGESTION |
3 |
0.0002 |
| 812 |
SOMNOLENCE |
38 |
0.0002 |
| 813 |
MYALGIA |
32 |
0.0002 |
| 814 |
FLUSHING |
19 |
0.0002 |
| 815 |
HIP FRACTURE |
6 |
0.0002 |
| 816 |
JAUNDICE |
5 |
0.0002 |
| 817 |
HOT FLUSH |
14 |
0.0002 |
| 818 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
4 |
0.0002 |
| 819 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 820 |
INTERVERTEBRAL DISC PROTRUSION |
4 |
0.0002 |
| 821 |
MOBILITY DECREASED |
13 |
0.0002 |
| 822 |
PRODUCT USE ISSUE |
34 |
0.0002 |
| 823 |
LIP SWELLING |
6 |
0.0002 |
| 824 |
TOOTH DISORDER |
4 |
0.0002 |
| 825 |
FEELING HOT |
11 |
0.0002 |
| 826 |
HYPERHIDROSIS |
23 |
0.0002 |
| 827 |
SNEEZING |
4 |
0.0002 |
| 828 |
MIGRAINE |
17 |
0.0002 |
| 829 |
DYSPNOEA |
100 |
0.0002 |
| 830 |
BLOOD PRESSURE INCREASED |
27 |
0.0002 |
| 831 |
PAIN IN JAW |
5 |
0.0002 |
| 832 |
DRUG INTOLERANCE |
17 |
0.0002 |
| 833 |
SINUSITIS |
18 |
0.0002 |
| 834 |
PERIPHERAL SWELLING |
27 |
0.0002 |
| 835 |
SCAR |
3 |
0.0002 |
| 836 |
RED BLOOD CELL COUNT DECREASED |
5 |
0.0002 |
| 837 |
COUGH |
49 |
0.0002 |
| 838 |
ILLNESS |
18 |
0.0002 |
| 839 |
TREMOR |
29 |
0.0002 |
| 840 |
MUSCULOSKELETAL DISCOMFORT |
3 |
0.0002 |
| 841 |
DRUG DEPENDENCE |
28 |
0.0002 |
| 842 |
TINNITUS |
8 |
0.0002 |
| 843 |
EYE IRRITATION |
10 |
0.0002 |
| 844 |
MUSCLE TWITCHING |
4 |
0.0002 |
| 845 |
FOETAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 846 |
NEEDLE ISSUE |
5 |
0.0002 |
| 847 |
HEART RATE INCREASED |
17 |
0.0002 |
| 848 |
EOSINOPHILIA |
3 |
0.0002 |
| 849 |
SLEEP DISORDER |
12 |
0.0002 |
| 850 |
PRODUCT USE IN UNAPPROVED INDICATION |
42 |
0.0002 |
| 851 |
VISUAL IMPAIRMENT |
21 |
0.0002 |
| 852 |
LABORATORY TEST ABNORMAL |
5 |
0.0002 |
| 853 |
SWELLING FACE |
11 |
0.0002 |
| 854 |
ARRHYTHMIA |
8 |
0.0002 |
| 855 |
PRODUCTIVE COUGH |
8 |
0.0002 |
| 856 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
8 |
0.0002 |
| 857 |
FATIGUE |
129 |
0.0002 |
| 858 |
CONTRAINDICATED PRODUCT ADMINISTERED |
5 |
0.0002 |
| 859 |
CORONARY ARTERY DISEASE |
5 |
0.0002 |
| 860 |
ACCIDENTAL OVERDOSE |
6 |
0.0002 |
| 861 |
MUSCLE SPASMS |
30 |
0.0002 |
| 862 |
HAEMORRHAGE |
17 |
0.0002 |
| 863 |
CARDIAC DISORDER |
15 |
0.0002 |
| 864 |
EYE PAIN |
9 |
0.0002 |
| 865 |
ASTHMA |
18 |
0.0002 |
| 866 |
FRACTURE |
3 |
0.0002 |
| 867 |
ANGIOEDEMA |
7 |
0.0002 |
| 868 |
DRUG INTERACTION |
25 |
0.0002 |
| 869 |
HEPATITIS |
4 |
0.0002 |
| 870 |
PAIN IN EXTREMITY |
46 |
0.0002 |
| 871 |
CONTUSION |
15 |
0.0002 |
| 872 |
DYSTONIA |
3 |
0.0002 |
| 873 |
RASH GENERALISED |
4 |
0.0002 |
| 874 |
APPLICATION SITE ERYTHEMA |
4 |
0.0002 |
| 875 |
BALANCE DISORDER |
13 |
0.0002 |
| 876 |
AGITATION |
11 |
0.0001 |
| 877 |
HOSPITALISATION |
23 |
0.0001 |
| 878 |
GAIT INABILITY |
5 |
0.0001 |
| 879 |
SWELLING |
14 |
0.0001 |
| 880 |
URTICARIA |
25 |
0.0001 |
| 881 |
FULL BLOOD COUNT DECREASED |
3 |
0.0001 |
| 882 |
EYE PRURITUS |
5 |
0.0001 |
| 883 |
DIZZINESS |
74 |
0.0001 |
| 884 |
DISTURBANCE IN ATTENTION |
8 |
0.0001 |
| 885 |
ILL-DEFINED DISORDER |
9 |
0.0001 |
| 886 |
DYSGEUSIA |
11 |
0.0001 |
| 887 |
ALOPECIA |
29 |
0.0001 |
| 888 |
COMA |
7 |
0.0001 |
| 889 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 890 |
HALLUCINATION |
11 |
0.0001 |
| 891 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
8 |
0.0001 |
| 892 |
MEMORY IMPAIRMENT |
20 |
0.0001 |
| 893 |
NECK PAIN |
8 |
0.0001 |
| 894 |
WEIGHT INCREASED |
32 |
0.0001 |
| 895 |
HEART RATE DECREASED |
5 |
0.0001 |
| 896 |
FEELING ABNORMAL |
34 |
0.0001 |
| 897 |
HYPERSENSITIVITY |
26 |
0.0001 |
| 898 |
LEUKOPENIA |
7 |
0.0001 |
| 899 |
CONVULSION |
8 |
0.0001 |
| 900 |
HYPOACUSIS |
6 |
0.0001 |
| 901 |
ELECTROCARDIOGRAM QT PROLONGED |
5 |
0.0001 |
| 902 |
MENTAL DISORDER |
6 |
0.0001 |
| 903 |
FLUID RETENTION |
7 |
0.0001 |
| 904 |
CHEST DISCOMFORT |
14 |
0.0001 |
| 905 |
SURGERY |
8 |
0.0001 |
| 906 |
DEPRESSION |
31 |
0.0001 |
| 907 |
DRY MOUTH |
11 |
0.0001 |
| 908 |
INJECTION SITE MASS |
5 |
0.0001 |
| 909 |
DRY SKIN |
18 |
0.0001 |
| 910 |
GLOSSODYNIA |
3 |
0.0001 |
| 911 |
CHROMATURIA |
3 |
0.0001 |
| 912 |
BLOOD GLUCOSE INCREASED |
25 |
0.0001 |
| 913 |
DEPRESSED MOOD |
7 |
0.0001 |
| 914 |
THERAPEUTIC RESPONSE DECREASED |
8 |
0.0001 |
| 915 |
VERTIGO |
8 |
0.0001 |
| 916 |
VISION BLURRED |
18 |
0.0001 |
| 917 |
SKIN IRRITATION |
6 |
0.0001 |
| 918 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 919 |
RASH PRURITIC |
7 |
0.0001 |
| 920 |
COGNITIVE DISORDER |
6 |
0.0001 |
| 921 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 922 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 923 |
DISEASE RECURRENCE |
6 |
0.0001 |
| 924 |
PRODUCT PRESCRIBING ERROR |
3 |
0.0001 |
| 925 |
INTENTIONAL PRODUCT USE ISSUE |
11 |
0.0001 |
| 926 |
DIABETIC KETOACIDOSIS |
3 |
0.0001 |
| 927 |
LOCALISED INFECTION |
3 |
0.0001 |
| 928 |
ANXIETY |
35 |
0.0001 |
| 929 |
BLINDNESS |
5 |
0.0001 |
| 930 |
EYE DISORDER |
4 |
0.0001 |
| 931 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 932 |
AGEUSIA |
3 |
0.0001 |
| 933 |
HYPOAESTHESIA |
18 |
0.0001 |
| 934 |
ROAD TRAFFIC ACCIDENT |
5 |
0.0001 |
| 935 |
WITHDRAWAL SYNDROME |
5 |
0.0001 |
| 936 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 937 |
DEVICE LEAKAGE |
5 |
0.0001 |
| 938 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 939 |
DEVICE DISLOCATION |
5 |
0.0001 |
| 940 |
PARAESTHESIA |
18 |
0.0001 |
| 941 |
ANHEDONIA |
3 |
0.0001 |
| 942 |
EAR INFECTION |
3 |
0.0001 |
| 943 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 944 |
ACNE |
8 |
0.0001 |
| 945 |
MYOCARDIAL INFARCTION |
18 |
0.0001 |
| 946 |
DYSPHONIA |
6 |
0.0001 |
| 947 |
MULTIPLE SCLEROSIS RELAPSE |
7 |
0.0001 |
| 948 |
INJECTION SITE REACTION |
7 |
0.0001 |
| 949 |
MATERNAL EXPOSURE DURING PREGNANCY |
9 |
0.0001 |
| 950 |
ABNORMAL BEHAVIOUR |
4 |
0.0001 |
| 951 |
LACRIMATION INCREASED |
3 |
0.0001 |
| 952 |
THERAPY INTERRUPTED |
7 |
0.0001 |
| 953 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 954 |
SKIN BURNING SENSATION |
7 |
0.0001 |
| 955 |
EMOTIONAL DISORDER |
3 |
0.0001 |
| 956 |
CEREBROVASCULAR ACCIDENT |
16 |
0.0001 |
| 957 |
EMOTIONAL DISTRESS |
11 |
0.0001 |
| 958 |
DEATH |
76 |
0.0001 |
| 959 |
GASTRIC DISORDER |
3 |
0.0001 |
| 960 |
THROMBOSIS |
7 |
0.0001 |
| 961 |
NASAL CONGESTION |
5 |
0.0001 |
| 962 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 963 |
IRRITABILITY |
5 |
0.0001 |
| 964 |
TOXICITY TO VARIOUS AGENTS |
14 |
0.0001 |
| 965 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 966 |
RESTLESSNESS |
3 |
0.0001 |
| 967 |
EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 968 |
AGGRESSION |
4 |
0.0001 |
| 969 |
RHEUMATOID ARTHRITIS |
9 |
0.0001 |
| 970 |
PLASMA CELL MYELOMA |
3 |
0.0001 |
| 971 |
PALPITATIONS |
9 |
0.0001 |
| 972 |
NERVOUSNESS |
4 |
0.0001 |
| 973 |
BREAST CANCER |
7 |
0.0001 |
| 974 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
15 |
0.0001 |
| 975 |
TREATMENT FAILURE |
6 |
0.0001 |
| 976 |
INJECTION SITE PAIN |
22 |
0.0001 |
| 977 |
JOINT SWELLING |
8 |
0.0001 |
| 978 |
UNEVALUABLE EVENT |
5 |
0.0001 |
| 979 |
AMNESIA |
4 |
0.0001 |
| 980 |
PRODUCT QUALITY ISSUE |
8 |
0.0001 |
| 981 |
DRUG WITHDRAWAL SYNDROME |
5 |
0.0001 |
| 982 |
ADVERSE EVENT |
5 |
0.0001 |
| 983 |
PRODUCT SUBSTITUTION ISSUE |
3 |
0.0001 |
| 984 |
INJECTION SITE ERYTHEMA |
6 |
0.0000 |
| 985 |
DEVICE ISSUE |
4 |
0.0000 |
| 986 |
INCORRECT DOSE ADMINISTERED |
10 |
0.0000 |
| 987 |
DEVICE MALFUNCTION |
3 |
0.0000 |
| 988 |
INJURY |
3 |
0.0000 |
| 989 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 990 |
PROSTATE CANCER |
3 |
0.0000 |
| 991 |
COMPLETED SUICIDE |
3 |
0.0000 |
| 992 |
DRUG DOSE OMISSION |
5 |
0.0000 |
| 993 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 994 |
NO ADVERSE EVENT |
5 |
0.0000 |